Literature DB >> 3225400

Effect of cimetidine on maternal and fetal prolactin secretion during labor.

I E Messinis1, N Tsirkas, K Diamantis, S Vasakos, O Tsolas, D Lolis.   

Abstract

Cimetidine, an H2 receptor antagonist, is a potent stimulant of PRL secretion in normal women. In the present study, the PRL response to cimetidine was studied in 34 normal pregnant women and their fetuses during labor. Serum maternal PRL levels increased significantly after the acute iv injection of 400 mg cimetidine 30-45 min before delivery (10 women) as compared to 7 control women given saline. However, PRL levels in serum of umbilical vein and artery did not increase. Similar results concerning PRL levels in umbilical vein and artery serum were obtained when cimetidine was injected 10-20 min (8 women), 60-75 min (8 women) and 90-120 min (8 women) before delivery. It is suggested that fetal pituitary lactotrops are not responsive to cimetidine stimulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3225400     DOI: 10.1007/BF03350225

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Serial prolactin and thyrotropin responses to thyrotropin-releasing hormone throughout normal human pregnancy.

Authors:  O Ylikorkala; S Kivinen; M Reinilä
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

2.  TRH injection during labour: effect on maternal and fetal prolactin secretion.

Authors:  I E Messinis; D E Lolis; N Kanellopoulos; N Dalkalitsis; C Kanaris
Journal:  Clin Endocrinol (Oxf)       Date:  1982-02       Impact factor: 3.478

3.  Effect of cimetidine on prolactin secretion in postpartum women.

Authors:  I E Messinis; A Souvatzoglou; N Fais; D Lolis
Journal:  Horm Metab Res       Date:  1983-07       Impact factor: 2.936

4.  Central nervous system-mediated stimulation of prolactin secretion by cimetidine, a histamine H2-receptor antagonist: impaired responsiveness in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.

Authors:  C Gonzalez-Villapando; M Szabo; L A Frohman
Journal:  J Clin Endocrinol Metab       Date:  1980-12       Impact factor: 5.958

5.  The acute effect of metoclopramide on plasma prolactin during pregnancy.

Authors:  J M Brandes; J Itskovitz; M Fisher; Z Shen-Orr; D Barzilai
Journal:  Acta Obstet Gynecol Scand       Date:  1981       Impact factor: 3.636

6.  Human cord blood concentrations of thyrotropin, thyroglobulin, and iodothyronines after maternal administration of thyrotropin-releasing hormone.

Authors:  E Roti; A Gnudi; L E Braverman; G Robuschi; R Emanuele; P Bandini; L Benassi; A Pagliani; C H Emerson
Journal:  J Clin Endocrinol Metab       Date:  1981-10       Impact factor: 5.958

7.  Effect of metoclopramide on maternal and fetal prolactin secretion during labor.

Authors:  I E Messinis; D E Lolis; N Dalkalitsis; C Kanaris; A Souvatzoglou
Journal:  Obstet Gynecol       Date:  1982-12       Impact factor: 7.661

8.  Histamine H1 receptor participation in the control of prolactin secretion in postpartum.

Authors:  I E Messinis; A Souvatzoglou; N Fais; D Lolis
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

9.  Prolactin responses to histamine H2 receptor antagonists.

Authors:  P C Sharpe; M A Melvin; J G Mills; W L Burland; G V Groom
Journal:  Acta Endocrinol (Copenh)       Date:  1980-11

10.  The effect of histamine and H1 and H2 receptors on prolactin and luteinizing hormone release in humans: sex differences and the role of stress.

Authors:  A E Pontiroli; E De Castro e Silva; F Mazzoleni; M Alberetto; G Baio; G Pellicciotta; A De Pasqua; L Stella; A M Girardi; G Pozza
Journal:  J Clin Endocrinol Metab       Date:  1981-05       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.